The note is the current scenario (Base). Download PDF renders this page on the server, fonts and colours exact; Print uses the browser.
Model Note · BIOCON LIMITED. · 11 September 2026Page 1 of 2
Model Note
Prepared by the reader · not a MarketPing document
BIOCON LIMITED. Discounted cash flow · base FY26
BIOCON LIMITED.
Value per share, this model₹(71)
CMP 2026-09-10₹390.65
Difference(118.1)%
Growth the CMP implies45.0%/yr
This note states the assumptions and the arithmetic of one model of BIOCON LIMITED., built on its filed FY26 consolidated statements. The value is the outcome of the assumptions below and nothing else; it is not a fair value, a target or a recommendation.
Assumptions
Input
This model
Filed reference
Revenue growth, 5 years
11% a year
FY26 10.9% · 5-yr CAGR 19.0%
EBITDA margin
18%
FY26 18.0% · 5-yr average 20.9%
Depreciation · capex, % of revenue
11.6% · 10.6%, fading to 1.2× depreciation
FY26 11.6% · 10.6%
Working capital, % of added revenue · tax
31.3% · 17.7%
114 working-capital days · effective 17.7%
Discount rate
11.00%
1-yr beta 0.66
After FY31
5% flat · mid-year discounting
—
Net debt · non-controlling interest · non-operating investments
₹12,408 · ₹0 · ₹0 cr
FY26 net debt ₹12,408 cr
Shares
162.97 crore
162.97 crore today
Source: SEBI results XBRL as filed with BSE/NSE, exchange prices; the reader's assumptions.
Projected cash flow to the firm
₹ crore
FY26
FY27
FY28
FY29
FY30
FY31
Revenue
16,927
18,789
20,856
23,150
25,696
28,523
growth %
10.9
11.0
11.0
11.0
11.0
11.0
EBITDA
3,052
3,382
3,754
4,167
4,625
5,134
Depreciation
(1,957)
(2,180)
(2,419)
(2,685)
(2,981)
(3,309)
NOPAT
902
990
1,099
1,219
1,353
1,502
less capex
(1,798)
(1,992)
(2,384)
(2,838)
(3,364)
(3,970)
less working-capital build
—
(583)
(647)
(718)
(797)
(885)
Free cash flow to firm
—
595
487
348
174
(44)
Present value
565
416
268
120
(28)
Source: the model; base year as filed.
Every figure is the reader's model over filed numbers · No rating, target or fair value is expressedmarketping.in
Model Note · BIOCON LIMITED. · 11 September 2026Page 2 of 2
From enterprise to equity
PV of the 5 explicit years
1,342
PV of the terminal value (-52% of EV)
(458)
Enterprise value
884
less net debt
(12,408)
less non-controlling interest
0
add non-operating investments
0
Equity value
(11,524)
÷ 162.97 crore shares
₹(71)
Source: the model.
Sensitivity, ₹ per share
WACC ↓ · terminal growth →
4.0%
4.5%
5.0%
5.5%
6.0%
10.0%
(71)
(71)
(71)
(72)
(72)
10.5%
(70)
(71)
(71)
(71)
(72)
11.0%
(70)
(70)
(71)
(71)
(71)
11.5%
(70)
(70)
(70)
(71)
(71)
12.0%
(70)
(70)
(70)
(70)
(71)
Source: the model; n/a where terminal growth reaches the discount rate.
Statement
This note is the reader's own model over publicly filed information: SEBI results XBRL filed with BSE and NSE and exchange price data, assembled by MarketPing software; every assumption above is the reader's. It contains no research recommendation, no price target and no opinion by MarketPing on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Historical per-share figures are on the current share count. Where a figure is unavailable the table shows a dash rather than an estimate. Nothing here constitutes investment advice, an offer or a solicitation.
Every figure is the reader's model over filed numbers · No rating, target or fair value is expressedmarketping.in
